Decreased graft survival in liver transplant recipients of donors with positive blood cultures: a review of the United Network for Organ Sharing dataset

被引:8
作者
Huaman, Moises A. [1 ,2 ]
Vilchez, Valery [3 ]
Mei, Xiaonan [4 ]
Shah, Malay B. [4 ]
Daily, Michael F. [4 ]
Berger, Jonathan [4 ]
Gedaly, Roberto [4 ]
机构
[1] Univ Kentucky, Dept Med, Coll Med, Div Infect Dis, Lexington, KY 40506 USA
[2] Univ Cincinnati, Coll Med, Dept Internal Med, Div Infect Dis, Cincinnati, OH USA
[3] Cleveland Clin Fdn, Dept Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA
[4] Univ Kentucky, Coll Med, Dept Surg, Sect Transplant Surg, Lexington, KY USA
基金
美国国家卫生研究院;
关键词
donor bacteremia; graft survival; infection; liver transplant; outcome; patient survival; TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODY; CONTROLLED-TRIAL; INFECTED DONORS; SEVERE SEPSIS; SEPTIC SHOCK; BACTEREMIA; MULTICENTER; INJURY;
D O I
10.1111/tri.12900
中图分类号
R61 [外科手术学];
学科分类号
摘要
Liver transplantation using blood culture positive donors (BCPD) has allowed a significant expansion of the donor pool. We aimed to characterize BCPD and assess the outcomes of BCPD liver transplant recipients. We retrieved data from the United Network for Organ Sharing (UNOS) registry on all adults who underwent primary, single-organ deceased-donor liver transplantation in the USA between 2008 and 2013. Patients were classified into two cohorts: the BCPD cohort and the non-BCPD cohort. One-year graft and patient survival were compared between cohorts using Kaplan-Meier estimates and Cox models. A total of 28 961 patients were included. There were 2316 (8.0%) recipients of BCPD. BCPD were more likely to be older, female, black, diabetic, hypertensive, and obese compared to non-BCPD. Graft survival was significantly lower in BCPD recipients compared to non-BCPD recipients (Kaplan-Meier, 0.85 vs. 0.87; P = 0.009). Results remained significant in propensity-matched analysis (P = 0.038). BCPD was independently associated with decreased graft survival (adjusted HR; 1.10, 95% CI 1.01-1.20; P = 0.04). There were no significant differences in patient survival between study groups. BCPD was associated with decreased graft survival in liver transplant recipients. Studies are needed to identify subgroups of BCPD with the highest risk of graft failure and characterize the underlying pathogenic mechanisms.
引用
收藏
页码:558 / 565
页数:8
相关论文
共 22 条
  • [1] Abraham E, 1998, LANCET, V351, P929
  • [2] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial
    Abraham, E
    Glauser, MP
    Butler, T
    Garbino, J
    Gelmont, D
    Laterre, PF
    Kudsk, K
    Bruining, HA
    Otto, C
    Tobin, E
    Zwingelstein, C
    Lesslauer, W
    Leighton, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19): : 1531 - 1538
  • [3] Incidence Rate and Outcome of Gram-Negative Bloodstream Infection in Solid Organ Transplant Recipients
    Al-Hasan, M. N.
    Razonable, R. R.
    Eckel-Passow, J. E.
    Baddour, L. M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (04) : 835 - 843
  • [4] Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
    Austin, Peter C.
    [J]. PHARMACEUTICAL STATISTICS, 2011, 10 (02) : 150 - 161
  • [5] Kidney transplants from infected donors: Our experience
    Battaglia, M
    Ditonno, P
    Selvaggio, O
    Garofalo, L
    Palazzo, S
    Schena, A
    Stallone, G
    D'Orazio, E
    Selvaggi, FP
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) : 491 - 492
  • [6] Variable selection for propensity score models
    Brookhart, M. Alan
    Schneeweiss, Sebastian
    Rothman, Kenneth J.
    Glynn, Robert J.
    Avorn, Jerry
    Sturmer, Til
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (12) : 1149 - 1156
  • [7] Bacterial- and fungal-positive cultures in organ donors: Clinical impact in liver transplantation
    Cerutti, Elisabetta
    Stratta, Chiara
    Romagnoli, Renato
    Serra, Roberto
    Lepore, Mirella
    Fop, Fabrizio
    Mascia, Luciana
    Lupo, Francesco
    Franchello, Alessandro
    Panio, Angelo
    Salizzoni, Mauro
    [J]. LIVER TRANSPLANTATION, 2006, 12 (08) : 1253 - 1259
  • [8] INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
    Cohen, J
    Carlet, J
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (09) : 1431 - 1440
  • [9] Donor-Derived Bacteremia in Liver Transplant Recipients Despite Antibiotic Prophylaxis
    Doucette, K. E.
    Al-Saif, M.
    Kneteman, N.
    Chui, L.
    Tyrrell, G. J.
    Kumar, D.
    Humar, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (04) : 1080 - 1083
  • [10] Cardiac Transplantation from Infected Donors: Is It Safe?
    Forest, Stephen J.
    Friedmann, Patricia
    Bello, Ricardo
    Goldstein, Daniel J.
    Muggia, Victoria
    D'Alessandro, David A.
    [J]. JOURNAL OF CARDIAC SURGERY, 2015, 30 (03) : 288 - 295